Masimo CEO Joe Kiani does not believe that Apple will be able to solve its patent infringement issues with software, reports Bloomberg. In an interview with Bloomberg TV, Kiani said that a software solution won’t work because Masimo patents cover hardware, not software. “I don’t think that could work — it shouldn’t — because our patents are not about the software,” said Kiani.
Apple is reportedly working to change the algorithms used for the blood oxygen sensor in the Apple Watch to skirt Masimo patents, with engineers aiming to adjust how oxygen saturation is determined and how the data is provided to customers. An Apple spokesperson said yesterday that Apple is planning to submit a workaround to the US Customs agency to determine whether a software change is enough to avoid an import ban.